Leap TherapeuticsLPTX
那斯達克 · USD
0.31
0.00
(-1.29%)
收盤 08/02 03:47 (UTC+8)
盤後
0
0
(0%)
08/02 03:47 (UTC+8)
Leap TherapeuticsLPTX
0.31
0.00
(-1.29%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 15,917 | - | - | 21,252 | 14,825 | 14,820 | 14,833 | 14,662 | 42,726 | 13,943 |
研發費用 | 12,911 | 13,112 | 14,915 | 17,885 | 11,299 | 11,685 | 11,503 | 11,104 | 38,942 | 11,034 |
推銷及管理費用 | 3,006 | 3,013 | 2,940 | 3,367 | 3,526 | 3,135 | 3,330 | 3,558 | 3,784 | 2,909 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -15,917 | -16,125 | -17,855 | -21,252 | -14,825 | -14,820 | -14,833 | -14,662 | -42,726 | -13,943 |
其他收入及費用 | 488 | 571 | 387 | 1,124 | 1,005 | 2,355 | 1,137 | 1,272 | 863 | 1,993 |
利息費用 | 6 | - | - | - | - | - | - | - | - | 5 |
稅前純益 | -15,435 | -15,554 | -17,468 | -20,128 | -13,820 | -12,465 | -13,696 | -13,390 | -41,863 | -11,955 |
所得稅 | - | -123 | 708 | - | - | - | - | - | - | 147 |
稅後純益 | -15,435 | -15,431 | -18,176 | -20,128 | -13,820 | -12,465 | -13,696 | -13,390 | -41,863 | -12,102 |
基本每股稅後盈餘(元) | -0.37 | -0.37 | -0.44 | -0.52 | -0.51 | - | -0.51 | -0.91 | -0.32 | -0.11 |
稀釋每股稅後盈餘(元) | -0.37 | -0.37 | -0.43 | -0.50 | -0.51 | -0.20 | 0.23 | -0.77 | -0.32 | -0.11 |
基本平均股數(千股) | 41268.00 | 41252.00 | 41209.00 | 39122.00 | 27014.00 | - | 26987.00 | 14710.00 | 129344.00 | 113239.00 |
稀釋平均股數(千股) | 41268.00 | 41252.00 | 41209.00 | 39122.00 | 27014.00 | - | 26987.00 | 14710.00 | 129344.00 | 113239.00 |
還原基本每股稅後盈餘(元) | -0.37 | -0.37 | -0.44 | -0.52 | -0.51 | - | -0.51 | -0.91 | -3.20 | -1.10 |
還原稀釋每股稅後盈餘(元) | -0.37 | -0.37 | -0.43 | -0.50 | -0.51 | -0.20 | 0.23 | -0.77 | -3.24 | -1.07 |
還原基本平均股數(千股) | 41,268 | 41,252 | 41,209 | 39,122 | 27,014 | - | 26,987 | 14,710 | 12,934 | 11,323 |
還原稀釋平均股數(千股) | 41,268 | 41,252 | 41,209 | 39,122 | 27,014 | - | 26,987 | 14,710 | 12,934 | 11,323 |
EBITDA(千元) | -15,429 | -15,554 | -17,468 | -20,128 | -13,815 | -12,461 | -13,693 | -13,184 | -41,759 | -11,946 |